By EnviroChemie GmbH
EnviroChemie tackles combined pharma and biotech wastewater decontamination challenge
Rossdorf, Germany: EnviroChemie has applied its world-leading expertise in effective water treatment solutions on behalf of a Southeast European biotech and pharma company that needs to purify its wastewater.
EnviroChemie is planning, building, and commissioning an advanced water treatment plant that will remove all traces of drug active pharmaceutical ingredients (APIs) from the company’s wastewater, making it safe for discharge back into the environment.
API residue challenge
Removing trace elements of active ingredients from drug production process water is one of the biggest challenges in modern industrial wastewater treatment. API residues pose a significant danger to humans, animals, and the environment but resist conventional water treatment methods, such as filtering.
The new pharma water treatment plant employs a combination of technologies to remove all dangerous drug chemical and biologically active elements.
End-to-end solution
EnviroChemie Laboratory experts in Rossdorf first determined the optimal process combination for removing all active ingredients (APIs) from the wastewater. The system was then designed and built in close coordination with the customer. The wastewater is treated with an innovative combination of Biomar biological processes, Flomar dissolved air flotation, and chemical-physical treatment steps.
The resulting plant was commissioned in October 2024 and can continuously process up to 46 cubic meters of wastewater per hour that can now be safely discharged back into the public sewerage system.
The client company also uses EnviroChemie’s digital service platform WaterExpert™ to manage daily plant operations. WaterExpert™ records data and supports analysis, guides workflows and provides troubleshooting information. The EnviroChemie solution package also includes supply of water chemicals and spare parts, system upkeep, mechanical and electrical maintenance, and regular process and management by results (MBR) checks.
About EnviroChemie
EnviroChemie GmbH has established a reputation for reliable and innovative technology for water and wastewater treatment and water recycling, specializing in developing and implementing tailor-made for customers in the pharmaceutical industry and life sciences.
This engineering company was founded in 1976 and offers a holistic range of “Made in Germany” branded products and services based on chemical-physical, biological and membrane filtration processes, whose pedigree relies on its long list of research achievements and patents.
EnviroChemie adopts a partnership approach in which client specialized needs and characteristics form the basis for individual design, planning, engineering, building and commissioning of pharmaceutical wastewater treatment plants. In terms of plant operation, EnviroChemie offers comprehensive services, operation management, contracting and water treatment chemicals.
With more than 30,000 plants sold worldwide, EnviroChemie can apply unrivalled experience to continuous development of innovative and reliable industrial water and wastewater technologies.
EnviroChemie is a member of the EnviroWater Group, a network of companies with specialists in the solution of a broad range of requirements for sustainable water treatment.
Further information at: www.envirochemie.com.
Resources
Click on EnviroChemie specialized solutions for wastewater treatment for laboratories and research institutes for further information.
Click on Pharma Biotechnology to learn more.